WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (70)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hampson, R. E.
Right arrow Articles by Deadwyler, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hampson, R. E.
Right arrow Articles by Deadwyler, S. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 1, 1998, 18(7):2740-2747

Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Enhancement of Delayed-Nonmatch-to-Sample Performance

Robert E. Hampson1, Gary Rogers2, Gary Lynch3, and Sam A. Deadwyler1

1 Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, 2 Cortex Pharmaceuticals, Irvine, California 92718, and 3 Department of Psychiatry, University of California, Irvine, California 92715

Ampakines are a family of drugs that selectively increase AMPA receptor-gated currents and improve performance on several behavioral tasks. This report describes evidence that ampakines cause a cumulative enhancement of performance in a spatial short-term memory task (). Two groups of rats were trained on a spatial variant of the delayed-nonmatch-to-sample (DNMS) paradigm. One group (n = 12) received the ampakine CX516 (Cortex Pharmaceuticals) alternated with vehicle for 17 consecutive days and then only vehicle for an additional 7 d. The second group (n = 6) received only vehicle injections over the same number of days. CX516 improved performance within sessions, particularly on trials with delays of 6-35 sec. In 9 of 12 rats, the positive effect of the drug was also present on nondrug days between CX516 administration and after cessation of CX516 injections. The animals that received only vehicle injections showed no improvement in DNMS performance over the entire 32 d of testing. Three of the 12 animals given CX516 did not exhibit "carryover" effects of the drug to the intervening (vehicle only) test sessions, but nonetheless exhibited superior performance during the first half of the session on days in which the ampakine was administered. Evaluation of errors suggests that the ampakine eliminated the necessity for a shift in response strategy that produced proactive interference on the following trial. Hippocampal involvement in these ampakine effects is discussed as a prelude to the second article in the series ().

Key words: ampakine; hippocampus; learning; memory; behavior; delay-dependent memory; proactive interference


Copyright © 1998 Society for Neuroscience  0270-6474/98/1872740-08$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Ogier, H. Wang, E. Hong, Q. Wang, M. E. Greenberg, and D. M. Katz
Brain-Derived Neurotrophic Factor Expression and Respiratory Function Improve after Ampakine Treatment in a Mouse Model of Rett Syndrome
J. Neurosci., October 3, 2007; 27(40): 10912 - 10917.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
J. A. Gray and B. L. Roth
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Schizophr Bull, September 1, 2007; 33(5): 1100 - 1119.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Bespalov, A.-L. Jongen-Relo, M. van Gaalen, S. Harich, H. Schoemaker, and G. Gross
Habituation Deficits Induced by Metabotropic Glutamate Receptors 2/3 Receptor Blockade in Mice: Reversal by Antipsychotic Drugs
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 944 - 950.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. S. Rex, J. C. Lauterborn, C.-Y. Lin, E. A. Kramar, G. A. Rogers, C. M. Gall, and G. Lynch
Restoration of Long-Term Potentiation in Middle-Aged Hippocampus After Induction of Brain-Derived Neurotrophic Factor
J Neurophysiol, August 1, 2006; 96(2): 677 - 685.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. M. Ramsey, M. M. Adams, O. J. Ariwodola, W. E. Sonntag, and J. L. Weiner
Functional Characterization of Des-IGF-1 Action at Excitatory Synapses in the CA1 Region of Rat Hippocampus
J Neurophysiol, July 1, 2005; 94(1): 247 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. K. Murray, K. Whalley, C. S. Robinson, M. A. Ward, C. A. Hicks, D. Lodge, J. L. Vandergriff, P. Baumbarger, E. Siuda, M. Gates, et al.
LY503430, a Novel {alpha}-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 752 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. D. Matzel, Y. R. Han, H. Grossman, M. S. Karnik, D. Patel, N. Scott, S. M. Specht, and C. C. Gandhi
Individual Differences in the Expression of a "General" Learning Ability in Mice
J. Neurosci., July 23, 2003; 23(16): 6423 - 6433.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
H. M. Fillit, R. N. Butler, A. W. O'Connell, M. S. Albert, J. E. Birren, C. W. Cotman, W. T. Greenough, P. E. Gold, A. F. Kramer, L. H. Kuller, et al.
Achieving and Maintaining Cognitive Vitality With Aging
Mayo Clin. Proc., July 1, 2002; 77(7): 681 - 696.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Baumbarger, M. Muhlhauser, J. Zhai, C. R. Yang, and E. S. Nisenbaum
Positive Modulation of alpha -Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors in Prefrontal Cortical Pyramidal Neurons by a Novel Allosteric Potentiator
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 86 - 102.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. C. Lauterborn, G. Lynch, P. Vanderklish, A. Arai, and C. M. Gall
Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons
J. Neurosci., January 1, 2000; 20(1): 8 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. E. Hampson, L. E. Jarrard, and S. A. Deadwyler
Effects of Ibotenate Hippocampal and Extrahippocampal Destruction on Delayed-Match and -Nonmatch-to-Sample Behavior in Rats
J. Neurosci., February 15, 1999; 19(4): 1492 - 1507.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. E. Hampson, G. Rogers, G. Lynch, and S. A. Deadwyler
Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Correlations with Hippocampal Neuronal Activity
J. Neurosci., April 1, 1998; 18(7): 2748 - 2763.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-